TABLE 2.
List of viral vector–based vaccine candidates under preclinical evaluation (WHO, 2021).
Developer/manufacturer | Type of vaccine candidate |
Nonreplicating viral vector–based vaccine candidates | |
---|---|
University of Helsinki/University of Eastern Finland | Ad 5 vector |
Theravectys-Institut Pasteur | Lentiviral vector |
ID Pharma | Sendai virus vector |
Ankara University | Adenovirus-based |
Massachusetts General Hospital/AveXis | AAVCOVID |
GeoVax/BravoVax | MVA-encoded VLP |
DZIF- German Center for Infection Research/DT Biologika GmbH | MVA-S encoded |
IDIBAPS-Hospital Clinic (Spain) | MVA-S |
AIOVA | Lentiviral vector |
Erciyes University | Adeno5-based |
Greffex | Ad5 S |
Stabilitech Biopharma Ltd | Oral Ad5 S |
Valo Therapeutics Ltd | Adenovirus-based + HLA-matched peptides |
Centro Nacional Biotecnologia (CNB-CSIC) (Spain) | MVA expressing structural proteins |
University of Georgia/University of Lowa | PIV5 |
Bharat Biotech/Thomas Jefferson University | Recombinant deactivated rabies virus containing S1 |
National Research Center (Egypt) | Influenza a H1N1 vector |
Icahn School of Medicine at Mount Sinai | Newcastle disease virus expressing S |
Vaxart | Oral vaccine platform |
Sorbonne University | Lentiviral vector Retro-VLP particles |
Replicating viral vector–based vaccine candidates | |
Farmacologicos Veterinarios SAC (FARVET SAC)/Universidad Peruana Cayetano Heredia (UPCH) | rNDV-FARVET expressing RBD |
KU Leuven | YF17D vector |
Cadila Healthcare Limited | Measles vector |
FBRI SRS VB VECTOR, Rospotrebnadzor, Koltsovo | Measles vector |
CanVirex AG/DZIF- German Center for Infection Research | Measles virus (S, N targets) |
Tonix Pharma/Southern Research | Horsepox vector expressing S protein |
BiOCAD/IEM | Attenuated influenza virus based live viral vectored vaccine |
FBRI SRC VB VECTOR, rospotrebnadzor, Koltsovo | Influenza–based recombinant vaccine |
Instituto Buntantan/Fundacao Oswaldo Cruz | Attenuated influenza expressing an antigenic portion of the spike protein |
University of Hong Kong | Influenza vector expressing RBD |
University of Manitoba | Replicating VSV vector–based DC-targeting |
University of Western Ontario | VSV-S |
Aurobindo | VSV-S |
FBRI SRC VB VECTOR, Rospotrebnadzor, Koltsovo | VSV vector |
UW-Madison, Bharat Biotech and FluGen | M2SR influenza vector |
Intravacc, Utrecht University, Wageningen Bioveterinary Research | NDV-SARS-CoV-2/Spike |
The Lancaster University (United Kingdom) | APMV |
Farvet SAC | rNDV-LS1-HN-RBD/SARS-CoV-2 |
Farvet SAC | rNDV-LS1-S1-F/SARS-CoV-2 |